Skip to main content
Clinical Trials/TCTR20210518002
TCTR20210518002
Recruiting
Phase 2

The comparison study of effectiveness of dry needling and ultrasound-guided interfascial hydrodissection at upper trapezius muscle in myofascial pain syndrome: A randomized controlled trial

Sirindhorn National Medical Rehabilitation Institute0 sites36 target enrollmentMay 18, 2021

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Myofascial pain syndrome at upper trapezius muscle
Sponsor
Sirindhorn National Medical Rehabilitation Institute
Enrollment
36
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 18, 2021
End Date
August 31, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sirindhorn National Medical Rehabilitation Institute

Eligibility Criteria

Inclusion Criteria

  • 1\. Age 18 to 70 years old
  • 2\. Be diagnosed by the physiatrist as Myofascial pain syndrome at upper trapezius muscle followed by Simon's criteria
  • 3\. Duration of pain from 2 weeks to 3 months with VAS at least 4
  • 4\. Have active trigger point at least 1 point at upper trapezius muscle
  • 5\. Understand Thai language, able to read and write the questionnaire, able to follow whole process of the trial

Exclusion Criteria

  • 1\.History and physical examination compatible with cervical radiculopathy or myelopathy
  • 2\.Rheumatologic disease such as rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus
  • 3\.History of surgery at cervical region
  • 4\. History of trauma at cervical region
  • 5\. Experience the treatment: dry needling, Interfascial hydrodissection, local injection, physical modalities and other physiotherapy session at shoulder and upper back region within 4 weeks before recruitment
  • 6\.Allergy to Paracetamol and NSAIDs in the Proprionic acid subgroup such as Naproxen, Ibuprofen
  • 7\.Pregnancy
  • 8\.Participants who request physiotherapy session, other medications, which are not Paracetamol and Naproxen, or other treatments at upper trapezius at shoulder and upper back region during the study

Outcomes

Primary Outcomes

Not specified

Similar Trials